The Enterprise Value as of November 2024 (TTM) for Immatics N.V. (IMTX) is 696.05M

According to Immatics N.V.’s latest financial reports and current stock price. The company's current Enterprise Value is 696.05M. This represents a change of 15.98% compared to the average of 600.14M of the last 4 quarters.

Immatics N.V. (IMTX) Historical Enterprise Value (quarterly & annually)

How has IMTX Enterprise Value performed in the past?

The mean historical Enterprise Value of Immatics N.V. over the last ten years is 466.91M. The current 696.05M Enterprise Value has changed 14.81% with respect to the historical average. Over the past ten years (40 quarters), IMTX's Enterprise Value was at its highest in in the June 2024 quarter at 1.04B. The Enterprise Value was at its lowest in in the September 2024 quarter at -173176000.00.

Immatics N.V. (IMTX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Immatics N.V. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Immatics N.V. (IMTX) Average Enterprise Value

How has IMTX Enterprise Value performed in the past?

The current Enterprise Value of Immatics N.V. (IMTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Immatics N.V. (IMTX) Enterprise Value vs. Peers

How is IMTX’s Enterprise Value compared to its peers?

Immatics N.V.’s Enterprise Value is less than Crinetics Pharmaceuticals, Inc. (4.93B), greater than ALX Oncology Holdings Inc. (68.10M), greater than BioAtla, Inc. (20.64M), greater than Aerovate Therapeutics, Inc. (46.23M), less than Keros Therapeutics, Inc. (1.75B), less than Syndax Pharmaceuticals, Inc. (1.24B), greater than Mineralys Therapeutics, Inc. (523.81M), less than Replimune Group, Inc. (984.10M), less than Janux Therapeutics, Inc. (2.64B), greater than Fennec Pharmaceuticals Inc. (105.60M), less than Edgewise Therapeutics, Inc. (3.01B), less than Harmony Biosciences Holdings, Inc. (1.74B), less than Inhibrx Biosciences, Inc. (0), greater than Merus N.V. (9.32M), less than Lyell Immunopharma, Inc. (2.68B), greater than Kronos Bio, Inc. (216.40M), greater than null (5.32M),

Build a custom stock screener for Immatics N.V. (IMTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Immatics N.V. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Immatics N.V. (IMTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Immatics N.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.